
Sevamob
Artificial intelligence based healthcare platform for organizations.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | N/A | Series A | |
Total Funding | 000k |
Related Content
Sevamob is a US-based company, founded in 2011 by Shelley Saxena, operating an AI-assisted disease management platform to address the scarcity of medical professionals and diagnostic services in underserved areas. The founder's personal experience with a family member's misdiagnosis served as the initial catalyst for the company's creation. Saxena, an alumnus of IIT Roorkee with an MBA from Cornell University, leveraged his prior experience managing products for IBM and co-founding a cloud-based mobile technology startup, Saasmob, to establish Sevamob. Initially launched in Lucknow, India, the company has since expanded its operations across more than 15 states in India, one US state, and has conducted pilots in Southern Africa.
The company's business model is primarily B2B, serving clients such as employers, corporate CSR initiatives, pharmaceutical companies, health insurers, hospitals, clinics, NGOs, and local governments. Revenue is generated through a hybrid model that includes technology licensing for its AI services and telehealth infrastructure, as well as direct healthcare service delivery. This approach enables Sevamob to provide primary care at a significantly reduced cost, in some cases up to 50% lower than traditional models. The company pivoted from an initial B2C subscription model to a more sustainable B2B group model to achieve scale and financial viability.
Sevamob's platform consists of two core components: AI-powered point-of-care diagnostics and health outcome delivery through telehealth and asset-light pop-up clinics. The mobile clinics offer a comprehensive suite of services, including consultations, point-of-care screening for various conditions, treatment for common ailments, and tracking of health outcomes using their proprietary technology. Their diagnostic capabilities cover blood, vision, urine, and sputum analysis. The telehealth marketplace facilitates video consultations and second opinions, connecting patients with a network of healthcare providers. This integrated system allows for efficient data collection and analytics, which also holds potential for ethical data monetization in the future.
Keywords: healthcare platform, AI diagnostics, telehealth, mobile clinics, primary care, disease management, point-of-care screening, B2B healthcare, health-tech, medical services, underserved markets, corporate social responsibility, remote healthcare, healthcare data analytics, subscription healthcare, value-based care, health outcome tracking, digital health India, rural healthcare, preventative care